Literature DB >> 12660731

The role of PI3K in immune cells.

Shigeo Koyasu1.   

Abstract

Members of the phosphoinositide-3 kinase (PI3K) family control several cellular responses including cell growth, survival, cytoskeletal remodeling and the trafficking of intracellular organelles in many different types of cell. In particular PI3K has important functions in the immune system. It has been difficult to evaluate the roles of distinct PI3Ks in cellular immune responses because no PI3K inhibitors are specific for individual family members and because most stimuli activate several PI3K enzymes. The development of gene-targeted mice now enables us to examine the physiological functions of individual PI3K enzymes in the immune system in vivo.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12660731     DOI： 10.1038/ni0403-313

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  152 in total

Review 1.  The secret ally: immunostimulation by anticancer drugs.

Authors:  Lorenzo Galluzzi; Laura Senovilla; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2012-02-03       Impact factor: 84.694

Review 2.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Fcepsilon- and Fcgamma-receptor signaling in diseases.

Authors:  Zen-Ichiro Honda
Journal:  Springer Semin Immunopathol       Date:  2006-11-15

4.  TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages.

Authors:  Christian P Bauerfeld; Ruchi Rastogi; Gaila Pirockinaite; Icksoo Lee; Maik Hüttemann; Bobby Monks; Morris J Birnbaum; Luigi Franchi; Gabriel Nuñez; Lobelia Samavati
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

5.  A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice.

Authors:  Jae-Hyeog Choi; Ki Hyang Kim; Kug-Hwan Roh; Hana Jung; Anbok Lee; Ji-Young Lee; Joo Yeon Song; Seung Jae Park; Ilhwan Kim; Won-Sik Lee; Su-Kil Seo; Il-Whan Choi; Yang-Xin Fu; Sung Su Yea; SaeGwang Park
Journal:  Oncoimmunology       Date:  2018-01-16       Impact factor: 8.110

6.  Expression and regulation of alarmin cytokine IL-1α in human retinal pigment epithelial cells.

Authors:  Zong-Mei Bian; Matthew G Field; Susan G Elner; Victor M Elner
Journal:  Exp Eye Res       Date:  2018-03-15       Impact factor: 3.467

7.  Protein kinase N1, a cell inhibitor of Akt kinase, has a central role in quality control of germinal center formation.

Authors:  Teruhito Yasui; Kaori Sakakibara-Yada; Taki Nishimura; Kentaro Morita; Satoru Tada; George Mosialos; Elliott Kieff; Hitoshi Kikutani
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

Review 8.  Role of diacylglycerol kinases in T cell development and function.

Authors:  Sruti Krishna; Xiaoping Zhong
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 9.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

10.  Transition from heterotypic to homotypic PDK1 homodimerization is essential for TCR-mediated NF-κB activation.

Authors:  Jung-Ah Kang; Sang Phil Jeong; Daeho Park; Matthew S Hayden; Sankar Ghosh; Sung-Gyoo Park
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.